Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
We all thought as much no idea hey !! Two words for you Value Investing !!
Read Warren Buffets book " The Warren Buffett Way" sounds like you need the advice !!
Good luck to you but if you have no idea and no clue don't invest get the fund mangers do it for you.
Cheers Hey !!!
That's one of the funniest things I've heard in a very long time, had my sides hurting.
Just keeping a watchful eye on the usual suspects over promoting this dog of Aim
Now no one's taking the bait, they're stuck with it but that's what you get for cheating
Couldn't happen to a better crew!
He has sold ages ago. He is now stalking the stock because he is not sure he has done the right thing.
Come on sun shine give me your number for the long term and net currents assets worth of BRH as of the last accounting period. Or otherwise you are on a road to no-where and you are embarrassing yourself.
And not answering my question does not sit well either
Any value has been sucked out and there's you left holding nothing but you'll keep on trying to convince yourself it's for the best, until it goes down further, which it invariably will.
Pure delusion and heavily driven by a few unsavoury characters on here, trying to entice other's to buy more, they cash out and laugh their knackers off until the next time.
It's all there in black and white
Telling the truth but that doesn't sit well here now does it?
Halma, have you still got shares in BRH?? If so why have you not listened to your own advice? If you have not, why you writing negative rubbish for no reason at all?
Jog on sunshine!!!
Good luck to you !! not sure you understand the process buy and hold, money at risk wait 5-10 years. in my opinion I see good intrinsic value , INTRINSIC VALUE !! I bet you don't even know the value of the Long term and net currents assets as of the last accounting period. If you did we wouldn't be having this conversation. !!
It's been going on for year's and it'll all fizzle out at the masters choosing
Investors have very little chance of coming out of this without a loss it's just how much?
So where are BRH in respect of the COVID test kits, money invested, but did we ever produce a finished, licensed product, that could be mass produced and on the shelf within days, or weeks,or months?
The words Take off and BRH definitely don't go hand in hand
Folk are selling out at 10.10p, so it might hover back around the 10p mark again tomorrow.
Something to look forward to!
The CX300 could become a workable analyser,it will enter a crowded field and will still need to overcome many regulatory and accreditation stages.
BRH has been promising much from paraytec,phasefocus and kirkstall for a number of years and as yet none have added any substantial value to the shareprice.
Last week I posed the question,that apart from the P2F dividend what has TB and BRH actually invested in that has produced a saleable asset? - there were no replies.
After this mornings RNS it looks like phasefocus is the best positioned asset,but in reality it is a share for the 20% traders for the foreseeable future.
We could get a buyer out of the blue
The way I look at it is that at least the money is working, its working in different ways and the risk is spread around.
Its a great RNS in my opinion the CX300 has shown as a diverse technological bit of kit which when applied with human ingenuity can be repurposed for different functionals in the medicine world, but the money invested by Braveheart is working with human effort behind it which when applied correctly in an ordered manner harvests results well done to Prof Carl Smythe. I think this is the tip of the iceberg sort of stuff and this can really make a difference.
Shareholders have to speculate to accumulate, I am yet to see a share that is a certain everything is risk , everything takes time to grow from trees to wheat and share prices, I am yet to see a farmer through his seed into the field one day and harvest the next, as well as making money from it even after doing it for 10 years. He generally gets better at it but everything takes time.
Patience is key but you want to be around and in the party when the RNS tells you its all good and the money worked hard and you now have returns. GOOD LUCK EVERYONE WHO IS A BRH BELIEVER !!
My guess is the party poppers will get there rewards for chipping away at the side-lines and go strangely quiet as they always do like apple stock nay Sayers did LOL !!
Best get some marmalade in
They'll be no jam here
Kicked further into the long grass.
More analytes being put into proof of concept whilst none being proved up.
There will be no firm interest in an analyser at this early stage - and why would there be.
Only one day of getting the RNS right but think we will get another one this week some time
More jam tomorrow, it's a very long road TB has been kicking this can down
You spoke about when it dropped from 16p ,,, I'm not looking for 16p again I'm looking for 16 pounds my old chap 🏖
Castle
GOV.UK / full backing
Gene therapies are medicines that modify a person’s genes to prevent, treat or cure disease.
The Gov know how important this is to succeed!!
https://www.google.com/url?sa=t&source=web&rct=j&opi=89978449&url=https://www.gov.uk/government/case-studies/horizon-scanning-case-study-developing-standards-for-adeno-associated-virus-gene-therapies&ved=2ahUKEwjG-9qwxfyBAxX8QkEAHSDoCxMQFnoECCEQAQ&usg=AOvVaw2CNJK0H6ZRRVDd4kU2-gZ3
Castle
The windfall could be huge, with treatments going for as much as $3.5 million a pop. One research firm says the market could be worth $82.2 billion by 2032. And with the snowballing number of gene therapies hitting the market, this slice of the biotech industry could be near an inflection point.15 Sept 2023
Hi starky ,,,
This is excellent progress and not long for manufacturing and yhe CX300 will fly of the shelves .
New science.......
Adeno-associated viruses, also known as AAV, are a type of virus that infects humans without causing a serious disease response. These viruses possess the unique ability to deliver DNA to specific cells in living organisms. Adeno-associated viruses cannot replicate on their own, which stops them from being able to grow and cause an infection in the body.
Castle
Good morning Castley ,Panic and all.
Excellent RNS with advancement of the Paraytec CX300. Congratulations to Prof Carl Smythe and the whole team.
Covid has not gone away and there will still be a need for rapid screening and so along with Sepsis pathogen identification this is yet another stream of revenue once the CX300 comes to market !
StarKnight
Patient is the key to success for our long term holders.